PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001140361-21-028002
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Net Income | -$588.93K | -$2.93M | -$3.89M | -$567.83K |
| EPS Diluted | -$0.03 | -$0.19 | -$0.75 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end
